Theresa Lii
This observational study will collect prospectively specified data on patient characteristics and clinically relevant outcomes in patients who receive a ketamine infusion at Stanford Pain Management Center for the treatment of chronic pain, with the goal of identifying treatment responders and relationships between patient characteristics and treatment response.
Ketamine is a type of anesthetic drug which has been used off-label to treat chronic pain. The effectiveness of intravenous ketamine and its duration of effect are not well-understood. There is high variability in response to ketamine, and it remains unclear which patient characteristics are associated with favorable outcomes. This observational study will collect a wide range of patient-reported outcomes via digital surveys: once at baseline before treatment, and up to 7 follow-up surveys for up to 12 months following a single ketamine infusion. Survey data will be supplemented by clinical da…
Inclusion Criteria: * Has been seen at Stanford's Pain Management Center for a doctor's visit at least once. * Is scheduled to undergo at least 1 ketamine infusion for the treatment of any chronic pain condition. * Have a valid email address and consents to receiving surveys by email. * Able to read, understand, and respond to English-language surveys on an electronic device such as a cell phone, tablet, or computer. * Able to read, understand, and provide written, dated informed consent. Exclusion Criteria: * Has their ketamine infusion cancelled, which may occur before or after consenting…
A multi-day continuous ketamine infusion delivered intravenously at subanesthetic doses in a monitored setting
Arctuva estimate
Actual pay is set by the research site.
Verify or correct the compensation shown for this listing.